Genetic Testing to Guide Warfarin Dosing: Impact of Direct Oral Anticoagulants

被引：5
|
作者：
Lentz, S. R. [1 ]
机构：
[1] Univ Iowa, Dept Internal Med, Carver Coll Med, Iowa City, IA 52242 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2016年 / 100卷 / 02期
关键词：
PHARMACOGENETICS; GENOTYPES;
D O I：
10.1002/cpt.395
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Despite rapid growth in the use of direct oral anticoagulants (DOACs), warfarin remains a widely prescribed anticoagulant drug. It is likely that the overall use of warfarin will continue to decline, but not completely disappear, as indications for DOACs expand. This changing anticoagulation landscape, along with the likelihood that personalized genomic information will become increasingly available, has several implications for the future of warfarin dosing strategies.
引用
收藏
页码：128 / 130
页数：4
相关论文
共 50 条
  • [21] Optimal dosing of warfarin and other coumarin anticoagulants: the role of genetic polymorphisms
    Ann K. Daly
    Archives of Toxicology, 2013, 87 : 407 - 420
  • [22] USING GENETIC TESTING TO GUIDE WARFARIN INITIATION DOSING AND DECREASING TIME TO ACHIEVE THERAPEUTIC INR
    McCotter, Craig J.
    Ferguson, Meridith
    Lennon, Carolyn
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1551 - E1551
  • [23] The newer direct oral anticoagulants: a practical guide
    Thachil, Jecko
    CLINICAL MEDICINE, 2014, 14 (02) : 165 - 175
  • [24] Direct oral anticoagulants: a guide for daily practice
    Fontana, Pierre
    Robert-Ebadi, Helia
    Bounameaux, Henri
    Boehlen, Francoise
    Righini, Marc
    SWISS MEDICAL WEEKLY, 2016, 146 : w14286
  • [25] Comparing intracerebral hemorrhages associated with direct oral anticoagulants or warfarin
    Kurogi, Ryota
    Nishimura, Kunihiro
    Nakai, Michikazu
    Kada, Akiko
    Kamitani, Satoru
    Nakagawara, Jyoji
    Toyoda, Kazunori
    Ogasawara, Kuniaki
    Ono, Junichi
    Shiokawa, Yoshiaki
    Aruga, Toru
    Miyachi, Shigeru
    Nagata, Izumi
    Matsuda, Shinya
    Yoshimura, Shinichi
    Okuchi, Kazuo
    Suzuki, Akifumi
    Nakamura, Fumiaki
    Onozuka, Daisuke
    Ido, Keisuke
    Kurogi, Ai
    Mukae, Nobutaka
    Nishimura, Ataru
    Arimura, Koichi
    Kitazono, Takanari
    Hagihara, Akihito
    Iihara, Koji
    NEUROLOGY, 2018, 90 (13) : E1143 - +
  • [26] Bleeding with direct oral anticoagulants vs warfarin: clinical experience
    Eikelboom, John
    Merli, Geno
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2016, 34 (11): : 3 - 8
  • [27] Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomes
    Kyle A. Davis
    Joel Joseph
    Sarah A. Nisly
    Journal of Thrombosis and Thrombolysis, 2020, 50 : 457 - 461
  • [28] Evaluation of Direct Oral Anticoagulants Versus Warfarin for Intracardiac Thromboses
    Iskaros, Olivia
    Marsh, Kassandra
    Papadopoulos, John
    Manmadhan, Arun
    Ahuja, Tania
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 77 (05) : 621 - 631
  • [29] Direct oral anticoagulants and warfarin safety in rural patients with obesity
    Caverley, Zachary R.
    Bindler, Ross J.
    Soh, Pamela
    Mendelson, Sherri
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2023, 365 (05): : 413 - 419
  • [30] Direct oral anticoagulants and warfarin in patients with cirrhosis: a comparison of outcomes
    Davis, Kyle A.
    Joseph, Joel
    Nisly, Sarah A.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 50 (02) : 457 - 461
12345